Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Dostinex Market Growth 2022-2028

  • LP 4869190
  • 77 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Dostinex will have significant change from previous year. According to our (LP Information) latest study, the global Dostinex market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Dostinex market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Dostinex market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Dostinex market, reaching US$ million by the year 2028. As for the Europe Dostinex landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Dostinex players cover Pfizer, Teva, Sun Pharmaceutical, and Mylan, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Dostinex market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

0.5mg/Pcs

1mg/Pcs

2mg/Pcs

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Parkinson's Disease (PD)

Hyperprolactinemia

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Pfizer

Teva

Sun Pharmaceutical

Mylan

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Dostinex Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Dostinex by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Dostinex by Country/Region, 2017, 2022 & 2028

2.2 Dostinex Segment by Type

2.2.1 0.5mg/Pcs

2.2.2 1mg/Pcs

2.2.3 2mg/Pcs

2.3 Dostinex Sales by Type

2.3.1 Global Dostinex Sales Market Share by Type (2017-2022)

2.3.2 Global Dostinex Revenue and Market Share by Type (2017-2022)

2.3.3 Global Dostinex Sale Price by Type (2017-2022)

2.4 Dostinex Segment by Application

2.4.1 Parkinson's Disease (PD)

2.4.2 Hyperprolactinemia

2.4.3 Other

2.5 Dostinex Sales by Application

2.5.1 Global Dostinex Sale Market Share by Application (2017-2022)

2.5.2 Global Dostinex Revenue and Market Share by Application (2017-2022)

2.5.3 Global Dostinex Sale Price by Application (2017-2022)

3 Global Dostinex by Company

3.1 Global Dostinex Breakdown Data by Company

3.1.1 Global Dostinex Annual Sales by Company (2020-2022)

3.1.2 Global Dostinex Sales Market Share by Company (2020-2022)

3.2 Global Dostinex Annual Revenue by Company (2020-2022)

3.2.1 Global Dostinex Revenue by Company (2020-2022)

3.2.2 Global Dostinex Revenue Market Share by Company (2020-2022)

3.3 Global Dostinex Sale Price by Company

3.4 Key Manufacturers Dostinex Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Dostinex Product Location Distribution

3.4.2 Players Dostinex Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Dostinex by Geographic Region

4.1 World Historic Dostinex Market Size by Geographic Region (2017-2022)

4.1.1 Global Dostinex Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Dostinex Annual Revenue by Geographic Region

4.2 World Historic Dostinex Market Size by Country/Region (2017-2022)

4.2.1 Global Dostinex Annual Sales by Country/Region (2017-2022)

4.2.2 Global Dostinex Annual Revenue by Country/Region

4.3 Americas Dostinex Sales Growth

4.4 APAC Dostinex Sales Growth

4.5 Europe Dostinex Sales Growth

4.6 Middle East & Africa Dostinex Sales Growth

5 Americas

5.1 Americas Dostinex Sales by Country

5.1.1 Americas Dostinex Sales by Country (2017-2022)

5.1.2 Americas Dostinex Revenue by Country (2017-2022)

5.2 Americas Dostinex Sales by Type

5.3 Americas Dostinex Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Dostinex Sales by Region

6.1.1 APAC Dostinex Sales by Region (2017-2022)

6.1.2 APAC Dostinex Revenue by Region (2017-2022)

6.2 APAC Dostinex Sales by Type

6.3 APAC Dostinex Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Dostinex by Country

7.1.1 Europe Dostinex Sales by Country (2017-2022)

7.1.2 Europe Dostinex Revenue by Country (2017-2022)

7.2 Europe Dostinex Sales by Type

7.3 Europe Dostinex Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Dostinex by Country

8.1.1 Middle East & Africa Dostinex Sales by Country (2017-2022)

8.1.2 Middle East & Africa Dostinex Revenue by Country (2017-2022)

8.2 Middle East & Africa Dostinex Sales by Type

8.3 Middle East & Africa Dostinex Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Dostinex

10.3 Manufacturing Process Analysis of Dostinex

10.4 Industry Chain Structure of Dostinex

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Dostinex Distributors

11.3 Dostinex Customer

12 World Forecast Review for Dostinex by Geographic Region

12.1 Global Dostinex Market Size Forecast by Region

12.1.1 Global Dostinex Forecast by Region (2023-2028)

12.1.2 Global Dostinex Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Dostinex Forecast by Type

12.7 Global Dostinex Forecast by Application

13 Key Players Analysis

13.1 Pfizer

13.1.1 Pfizer Company Information

13.1.2 Pfizer Dostinex Product Offered

13.1.3 Pfizer Dostinex Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Pfizer Main Business Overview

13.1.5 Pfizer Latest Developments

13.2 Teva

13.2.1 Teva Company Information

13.2.2 Teva Dostinex Product Offered

13.2.3 Teva Dostinex Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Teva Main Business Overview

13.2.5 Teva Latest Developments

13.3 Sun Pharmaceutical

13.3.1 Sun Pharmaceutical Company Information

13.3.2 Sun Pharmaceutical Dostinex Product Offered

13.3.3 Sun Pharmaceutical Dostinex Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Sun Pharmaceutical Main Business Overview

13.3.5 Sun Pharmaceutical Latest Developments

13.4 Mylan

13.4.1 Mylan Company Information

13.4.2 Mylan Dostinex Product Offered

13.4.3 Mylan Dostinex Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Mylan Main Business Overview

13.4.5 Mylan Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Dostinex Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Dostinex Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of 0.5mg/Pcs

Table 4. Major Players of 1mg/Pcs

Table 5. Major Players of 2mg/Pcs

Table 6. Global Dostinex Sales by Type (2017-2022) & (K Units)

Table 7. Global Dostinex Sales Market Share by Type (2017-2022)

Table 8. Global Dostinex Revenue by Type (2017-2022) & ($ million)

Table 9. Global Dostinex Revenue Market Share by Type (2017-2022)

Table 10. Global Dostinex Sale Price by Type (2017-2022) & (US$/Unit)

Table 11. Global Dostinex Sales by Application (2017-2022) & (K Units)

Table 12. Global Dostinex Sales Market Share by Application (2017-2022)

Table 13. Global Dostinex Revenue by Application (2017-2022)

Table 14. Global Dostinex Revenue Market Share by Application (2017-2022)

Table 15. Global Dostinex Sale Price by Application (2017-2022) & (US$/Unit)

Table 16. Global Dostinex Sales by Company (2020-2022) & (K Units)

Table 17. Global Dostinex Sales Market Share by Company (2020-2022)

Table 18. Global Dostinex Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Dostinex Revenue Market Share by Company (2020-2022)

Table 20. Global Dostinex Sale Price by Company (2020-2022) & (US$/Unit)

Table 21. Key Manufacturers Dostinex Producing Area Distribution and Sales Area

Table 22. Players Dostinex Products Offered

Table 23. Dostinex Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Dostinex Sales by Geographic Region (2017-2022) & (K Units)

Table 27. Global Dostinex Sales Market Share Geographic Region (2017-2022)

Table 28. Global Dostinex Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Dostinex Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Dostinex Sales by Country/Region (2017-2022) & (K Units)

Table 31. Global Dostinex Sales Market Share by Country/Region (2017-2022)

Table 32. Global Dostinex Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Dostinex Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Dostinex Sales by Country (2017-2022) & (K Units)

Table 35. Americas Dostinex Sales Market Share by Country (2017-2022)

Table 36. Americas Dostinex Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Dostinex Revenue Market Share by Country (2017-2022)

Table 38. Americas Dostinex Sales by Type (2017-2022) & (K Units)

Table 39. Americas Dostinex Sales Market Share by Type (2017-2022)

Table 40. Americas Dostinex Sales by Application (2017-2022) & (K Units)

Table 41. Americas Dostinex Sales Market Share by Application (2017-2022)

Table 42. APAC Dostinex Sales by Region (2017-2022) & (K Units)

Table 43. APAC Dostinex Sales Market Share by Region (2017-2022)

Table 44. APAC Dostinex Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Dostinex Revenue Market Share by Region (2017-2022)

Table 46. APAC Dostinex Sales by Type (2017-2022) & (K Units)

Table 47. APAC Dostinex Sales Market Share by Type (2017-2022)

Table 48. APAC Dostinex Sales by Application (2017-2022) & (K Units)

Table 49. APAC Dostinex Sales Market Share by Application (2017-2022)

Table 50. Europe Dostinex Sales by Country (2017-2022) & (K Units)

Table 51. Europe Dostinex Sales Market Share by Country (2017-2022)

Table 52. Europe Dostinex Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Dostinex Revenue Market Share by Country (2017-2022)

Table 54. Europe Dostinex Sales by Type (2017-2022) & (K Units)

Table 55. Europe Dostinex Sales Market Share by Type (2017-2022)

Table 56. Europe Dostinex Sales by Application (2017-2022) & (K Units)

Table 57. Europe Dostinex Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Dostinex Sales by Country (2017-2022) & (K Units)

Table 59. Middle East & Africa Dostinex Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Dostinex Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Dostinex Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Dostinex Sales by Type (2017-2022) & (K Units)

Table 63. Middle East & Africa Dostinex Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Dostinex Sales by Application (2017-2022) & (K Units)

Table 65. Middle East & Africa Dostinex Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Dostinex

Table 67. Key Market Challenges & Risks of Dostinex

Table 68. Key Industry Trends of Dostinex

Table 69. Dostinex Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Dostinex Distributors List

Table 72. Dostinex Customer List

Table 73. Global Dostinex Sales Forecast by Region (2023-2028) & (K Units)

Table 74. Global Dostinex Sales Market Forecast by Region

Table 75. Global Dostinex Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Dostinex Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Dostinex Sales Forecast by Country (2023-2028) & (K Units)

Table 78. Americas Dostinex Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Dostinex Sales Forecast by Region (2023-2028) & (K Units)

Table 80. APAC Dostinex Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Dostinex Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Europe Dostinex Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Dostinex Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Middle East & Africa Dostinex Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Dostinex Sales Forecast by Type (2023-2028) & (K Units)

Table 86. Global Dostinex Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Dostinex Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Dostinex Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Dostinex Sales Forecast by Application (2023-2028) & (K Units)

Table 90. Global Dostinex Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Dostinex Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Dostinex Revenue Market Share Forecast by Application (2023-2028)

Table 93. Pfizer Basic Information, Dostinex Manufacturing Base, Sales Area and Its Competitors

Table 94. Pfizer Dostinex Product Offered

Table 95. Pfizer Dostinex Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 96. Pfizer Main Business

Table 97. Pfizer Latest Developments

Table 98. Teva Basic Information, Dostinex Manufacturing Base, Sales Area and Its Competitors

Table 99. Teva Dostinex Product Offered

Table 100. Teva Dostinex Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 101. Teva Main Business

Table 102. Teva Latest Developments

Table 103. Sun Pharmaceutical Basic Information, Dostinex Manufacturing Base, Sales Area and Its Competitors

Table 104. Sun Pharmaceutical Dostinex Product Offered

Table 105. Sun Pharmaceutical Dostinex Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 106. Sun Pharmaceutical Main Business

Table 107. Sun Pharmaceutical Latest Developments

Table 108. Mylan Basic Information, Dostinex Manufacturing Base, Sales Area and Its Competitors

Table 109. Mylan Dostinex Product Offered

Table 110. Mylan Dostinex Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 111. Mylan Main Business

Table 112. Mylan Latest Developments

List of Figures

Figure 1. Picture of Dostinex

Figure 2. Dostinex Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Dostinex Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Dostinex Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Dostinex Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of 0.5mg/Pcs

Figure 10. Product Picture of 1mg/Pcs

Figure 11. Product Picture of 2mg/Pcs

Figure 12. Global Dostinex Sales Market Share by Type in 2021

Figure 13. Global Dostinex Revenue Market Share by Type (2017-2022)

Figure 14. Dostinex Consumed in Parkinson's Disease (PD)

Figure 15. Global Dostinex Market: Parkinson's Disease (PD) (2017-2022) & (K Units)

Figure 16. Dostinex Consumed in Hyperprolactinemia

Figure 17. Global Dostinex Market: Hyperprolactinemia (2017-2022) & (K Units)

Figure 18. Dostinex Consumed in Other

Figure 19. Global Dostinex Market: Other (2017-2022) & (K Units)

Figure 20. Global Dostinex Sales Market Share by Application (2017-2022)

Figure 21. Global Dostinex Revenue Market Share by Application in 2021

Figure 22. Dostinex Revenue Market by Company in 2021 ($ Million)

Figure 23. Global Dostinex Revenue Market Share by Company in 2021

Figure 24. Global Dostinex Sales Market Share by Geographic Region (2017-2022)

Figure 25. Global Dostinex Revenue Market Share by Geographic Region in 2021

Figure 26. Global Dostinex Sales Market Share by Region (2017-2022)

Figure 27. Global Dostinex Revenue Market Share by Country/Region in 2021

Figure 28. Americas Dostinex Sales 2017-2022 (K Units)

Figure 29. Americas Dostinex Revenue 2017-2022 ($ Millions)

Figure 30. APAC Dostinex Sales 2017-2022 (K Units)

Figure 31. APAC Dostinex Revenue 2017-2022 ($ Millions)

Figure 32. Europe Dostinex Sales 2017-2022 (K Units)

Figure 33. Europe Dostinex Revenue 2017-2022 ($ Millions)

Figure 34. Middle East & Africa Dostinex Sales 2017-2022 (K Units)

Figure 35. Middle East & Africa Dostinex Revenue 2017-2022 ($ Millions)

Figure 36. Americas Dostinex Sales Market Share by Country in 2021

Figure 37. Americas Dostinex Revenue Market Share by Country in 2021

Figure 38. United States Dostinex Revenue Growth 2017-2022 ($ Millions)

Figure 39. Canada Dostinex Revenue Growth 2017-2022 ($ Millions)

Figure 40. Mexico Dostinex Revenue Growth 2017-2022 ($ Millions)

Figure 41. Brazil Dostinex Revenue Growth 2017-2022 ($ Millions)

Figure 42. APAC Dostinex Sales Market Share by Region in 2021

Figure 43. APAC Dostinex Revenue Market Share by Regions in 2021

Figure 44. China Dostinex Revenue Growth 2017-2022 ($ Millions)

Figure 45. Japan Dostinex Revenue Growth 2017-2022 ($ Millions)

Figure 46. South Korea Dostinex Revenue Growth 2017-2022 ($ Millions)

Figure 47. Southeast Asia Dostinex Revenue Growth 2017-2022 ($ Millions)

Figure 48. India Dostinex Revenue Growth 2017-2022 ($ Millions)

Figure 49. Australia Dostinex Revenue Growth 2017-2022 ($ Millions)

Figure 50. Europe Dostinex Sales Market Share by Country in 2021

Figure 51. Europe Dostinex Revenue Market Share by Country in 2021

Figure 52. Germany Dostinex Revenue Growth 2017-2022 ($ Millions)

Figure 53. France Dostinex Revenue Growth 2017-2022 ($ Millions)

Figure 54. UK Dostinex Revenue Growth 2017-2022 ($ Millions)

Figure 55. Italy Dostinex Revenue Growth 2017-2022 ($ Millions)

Figure 56. Russia Dostinex Revenue Growth 2017-2022 ($ Millions)

Figure 57. Middle East & Africa Dostinex Sales Market Share by Country in 2021

Figure 58. Middle East & Africa Dostinex Revenue Market Share by Country in 2021

Figure 59. Egypt Dostinex Revenue Growth 2017-2022 ($ Millions)

Figure 60. South Africa Dostinex Revenue Growth 2017-2022 ($ Millions)

Figure 61. Israel Dostinex Revenue Growth 2017-2022 ($ Millions)

Figure 62. Turkey Dostinex Revenue Growth 2017-2022 ($ Millions)

Figure 63. GCC Country Dostinex Revenue Growth 2017-2022 ($ Millions)

Figure 64. Manufacturing Cost Structure Analysis of Dostinex in 2021

Figure 65. Manufacturing Process Analysis of Dostinex

Figure 66. Industry Chain Structure of Dostinex

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390